Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-12-19A Phase 1, Dose Escalation, Open-Label Study of Intratumoral CAN2109 in Subjects With Unresectable or Metastatic Advanced Solid Tumors.
-
CLINICAL_TRIALS study record update · 2024-12-17A Case-Control Study To Determine The Suitability Of Artificial Intelligence For Leukemia Diagnostics
-
CLINICAL_TRIALS study record update · 2024-12-17Metabolic Insights: the Impact of F-18 FDG PET/CT in Adult Lymphoma
-
CLINICAL_TRIALS study record update · 2024-12-12A Phase I Clinical Trial with CAR-37 T Cells for the Treatment of Patients with Relapsed or Refractory CD37+ Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2024-12-11A Multi-centre, Non-interventional Retrospective Study to Describe Treatment Pathways, Outcomes, and Resource Use in Patients With CD30 Positive Lymphoma in China (REALM)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-12-10A Phase I Study of Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas
-
CLINICAL_TRIALS study record update · 2024-12-09The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia Reality: a Qualitative Study and Framework Analysis
-
CLINICAL_TRIALS study record update · 2024-12-03A Pilot Study of Lenalidomide Alternating With Ipilimumab Post Allogeneic and Autologous Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2024-12-03Mediastinal Recurrence of Lympho-proliferative Disorders: a Biopsy is Needed
-
CLINICAL_TRIALS study record update · 2024-11-19An Open Label, Dose-Escalation, Phase 1/2 Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of TAK-981 in Adult Patients With Advanced or Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2024-11-12A Phase I Study of Safety, Tolerability and Pharmacokinetics of T-1301 Capsules in Subjects with Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-11-12IIT2017-03-Merin-HaploBFR: Bendamustine, Fludarabine, and Rituximab Conditioning for Haploidentical Stem Cell Transplantation with CD56-Enriched Donor Cell Infusion for Relapsed/Refractory Lymphoma, Multiple Myeloma, and CLL
-
CLINICAL_TRIALS study record update · 2024-11-08Supporting Older Adults With Cancer and Their Support Person Through Geriatric Assessment and Remote Exercise and Education: the SOAR Study
-
CLINICAL_TRIALS study record update · 2024-11-07The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer Patients
-
CLINICAL_TRIALS study record update · 2024-11-06A PHASE I, OPEN LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF TTI-622 (PF-07901801), A SINGLE AGENT IN JAPANESE PARTICIPANTS WITH RELAPSED OR REFRACTORY LYMPHOMA
-
CLINICAL_TRIALS study record update · 2024-11-01Effects Of Meditation On The Gut Microbiome And Human Health and Disease
-
CLINICAL_TRIALS study record update · 2024-10-31An Open-Label, Dose-Escalation/Expansion Phase 1 Study of ASP4132 Given Orally to Patients With Advanced Refractory Solid Tumors and Lymphoma
-
CLINICAL_TRIALS study record update · 2024-10-18Eltrombopag Plus G-CSF for Human CD34+ Cell Mobilization in Patients With Lymphoma Undergoing Autologous Stem Cell Harvest
-
CLINICAL_TRIALS study record update · 2024-10-16Exercise-induced Adrenergic Receptor Signaling as an Immune Adjuvant for Allogeneic Cell Therapies
-
CLINICAL_TRIALS study record update · 2024-10-10A Phase I Open Label Study of HG146 Alone /in Combination with PD-(L)1 Inhibitor Administered with and Without Anticancer Agents in Participants with Advanced Solid Tumors or Lymphoma
-
CLINICAL_TRIALS study record update · 2024-10-09A Phase Ib-II Study of Tazemetostat (EPZ-6438) in Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL) or High Risk Follicular Lymphoma (FL) Patients Treated by R-CHOP
-
CLINICAL_TRIALS study record update · 2024-10-02Phase 1 Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 (CC-90010) in Pediatric Cancer
-
CLINICAL_TRIALS study record update · 2024-09-25Impact of Chemotherapeutic Treatments on Functional Autonomy and Quality of Life in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy
-
CLINICAL_TRIALS study record update · 2024-09-23A Phase III Randomized Trial of CHOP Chemotherapy Plus Rituxan (IDEC-C2B8) Versus CHOP Chemotherapy Alone for Newly Diagnosed, Previously Untreated, Aggressive Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2024-09-19A Single Arm, Open Center, Multicenter Clinical Study of Frontline Treatment of Marginal Zone Lymphoma Patients (MZL) With Linperlisib Combined With Obinutuzumab